Mylan Settles With Orion Over Planned Stalevo Generic
Mylan Inc. on Thursday announced it had reached a settlement with Orion Corp. over its planned generic version of Parkinson's disease treatment Stalevo, ending a patent infringement dispute in Delaware federal...To view the full article, register now.
Already a subscriber? Click here to view full article